GMO US Quality ETF
QLTY
119 hedge funds and large institutions have $1.9B invested in GMO US Quality ETF in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 58 increasing their positions, 30 reducing their positions, and 4 closing their positions.
250% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 4
93% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 30
32% more capital invested
Capital invested by funds: $1.44B → $1.9B (+$466M)
20% more funds holding in top 10
Funds holding in top 10: 15 → 18 (+3)
7% more funds holding
Funds holding: 111 → 119 (+8)
4.28% more ownership
Funds ownership: 71.9% → 76.17% (+4.3%)
Top Buyers
Top Sellers
QLTY Hedge Fund Activity: Q3 2025 in Review
119 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in GMO US Quality ETF (QLTY) for Q3 2025, worth a combined $1.9B — up 32% from $1.44B a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new QLTY positions and 4 closed out — a net gain of 10 holders — while 58 added to existing stakes and 30 trimmed.
The largest buyer was AIA Group, adding an estimated $179M. The largest seller was Raymond James Financial, cutting an estimated $17.1M.
- 119 institutional investors held GMO US Quality ETF (QLTY) as of Q3 2025, up from 111 in Q2 2025.
- Funds reported $1.9B of GMO US Quality ETF stock for Q3 2025, up 32% quarter-over-quarter.
- 14 funds opened new GMO US Quality ETF positions in Q3 2025 and 4 closed out, a net change of +10 holders.
- The largest GMO US Quality ETF buyer in Q3 2025 was AIA Group, an estimated $179M added.
- The largest GMO US Quality ETF seller in Q3 2025 was Raymond James Financial, an estimated $17.1M sold.
Based on aggregated 13F filings for Q3 2025.